<s id="wsj_2099.1"> 31
1 	 0 	 N/N 	 1 	 Corp. Unilab
1 	 7 	 (S[dcl]\NP)/S[dcl] 	 1 	 Corp. said
3 	 7 	 (S[dcl]\NP)/S[dcl] 	 1 	 Norcross said
5 	 7 	 (S[dcl]\NP)/S[dcl] 	 1 	 Ga. said
8 	 9 	 (S[dcl]\NP)/NP 	 1 	 it acquired
9 	 7 	 (S[dcl]\NP)/S[dcl] 	 2 	 acquired said
9 	 20 	 ((S\NP)\(S\NP))/NP 	 2 	 acquired in
12 	 9 	 (S[dcl]\NP)/NP 	 2 	 laboratories acquired
12 	 10 	 NP[nb]/N 	 1 	 laboratories the
12 	 11 	 N/N 	 1 	 laboratories clinical
12 	 13 	 (NP\NP)/NP 	 1 	 laboratories of
15 	 14 	 (N/N)/(N/N) 	 2 	 held closely
19 	 13 	 (NP\NP)/NP 	 2 	 Inc. of
19 	 15 	 N/N 	 1 	 Inc. held
19 	 16 	 N/N 	 1 	 Inc. Central
19 	 17 	 N/N 	 1 	 Inc. Diagnostic
19 	 18 	 N/N 	 1 	 Inc. Laboratory
25 	 20 	 ((S\NP)\(S\NP))/NP 	 3 	 transaction in
25 	 21 	 NP[nb]/N 	 1 	 transaction a
25 	 22 	 N/N 	 1 	 transaction cash
25 	 24 	 N/N 	 1 	 transaction securities
25 	 26 	 (S[pss]\NP)/PP 	 1 	 transaction valued <XB>
27 	 26 	 (S[pss]\NP)/PP 	 2 	 at valued
28 	 27 	 PP/NP 	 1 	 $ at
30 	 28 	 N/N[num] 	 1 	 million $
30 	 29 	 N/N 	 1 	 million 85
<\s>
<s id="wsj_2099.2"> 37
0 	 1 	 (S[dcl]\NP)/S[dcl] 	 1 	 Unilab said
4 	 3 	 (N/N)/(N/N) 	 2 	 owned wholly
7 	 2 	 NP[nb]/N 	 1 	 unit its
7 	 4 	 N/N 	 1 	 unit owned
7 	 5 	 N/N 	 1 	 unit MetWest
7 	 6 	 N/N 	 1 	 unit Inc.
7 	 8 	 ((S[dcl]\NP)/(S[pt]\NP))/NP 	 1 	 unit paid
7 	 29 	 (S[b]\NP)/NP 	 1 	 unit acquire <XB>
8 	 1 	 (S[dcl]\NP)/S[dcl] 	 2 	 paid said
9 	 8 	 ((S[dcl]\NP)/(S[pt]\NP))/NP 	 3 	 $ paid
9 	 12 	 (NP\NP)/NP 	 1 	 $ in
9 	 15 	 (S[pt]\NP)/NP 	 1 	 $ provided <XB>
11 	 9 	 N/N[num] 	 1 	 million $
11 	 10 	 N/N 	 1 	 million 25
13 	 12 	 (NP\NP)/NP 	 2 	 cash in
15 	 8 	 ((S[dcl]\NP)/(S[pt]\NP))/NP 	 2 	 provided paid
16 	 15 	 (S[pt]\NP)/NP 	 2 	 $ provided
16 	 19 	 (NP\NP)/NP 	 1 	 $ in
18 	 16 	 N/N[num] 	 1 	 million $
18 	 17 	 N/N 	 1 	 million 30
20 	 19 	 (NP\NP)/NP 	 2 	 notes in
22 	 15 	 (S[pt]\NP)/NP 	 2 	 $ provided
22 	 25 	 (NP\NP)/NP 	 1 	 $ in
24 	 22 	 N/N[num] 	 1 	 million $
24 	 23 	 N/N 	 1 	 million 30
27 	 25 	 (NP\NP)/NP 	 2 	 stock in
27 	 26 	 N/N 	 1 	 stock preferred
29 	 28 	 (S[to]\NP)/(S[b]\NP) 	 2 	 acquire to
30 	 31 	 (NP[nb]/N)\NP 	 2 	 Central 's
32 	 29 	 (S[b]\NP)/NP 	 2 	 labs acquire
32 	 31 	 (NP[nb]/N)\NP 	 1 	 labs 's
32 	 33 	 (NP\NP)/NP 	 1 	 labs in
36 	 33 	 (NP\NP)/NP 	 2 	 U.S. in
36 	 34 	 NP[nb]/N 	 1 	 U.S. the
36 	 35 	 N/N 	 1 	 U.S. Western
<\s>
<s id="wsj_2099.3"> 23
0 	 2 	 (NP\NP)/(S[dcl]\NP) 	 1 	 Unilab which
0 	 3 	 (S[dcl]\NP)/NP 	 1 	 Unilab provides <XB>
0 	 8 	 (S[dcl]\NP)/PP 	 1 	 Unilab competed
3 	 2 	 (NP\NP)/(S[dcl]\NP) 	 2 	 provides which
6 	 3 	 (S[dcl]\NP)/NP 	 2 	 services provides
6 	 4 	 N/N 	 1 	 services clinical
6 	 5 	 N/N 	 1 	 services laboratory
8 	 18 	 ((S\NP)\(S\NP))/NP 	 2 	 competed in
9 	 8 	 (S[dcl]\NP)/PP 	 2 	 with competed
10 	 9 	 PP/NP 	 1 	 Central with
10 	 12 	 S[pss]\NP 	 1 	 Central based <XB>
12 	 13 	 ((S\NP)\(S\NP))/NP 	 2 	 based in
14 	 13 	 ((S\NP)\(S\NP))/NP 	 3 	 Tarzana in
16 	 13 	 ((S\NP)\(S\NP))/NP 	 3 	 Calif. in
20 	 18 	 ((S\NP)\(S\NP))/NP 	 3 	 number in
20 	 19 	 NP[nb]/N 	 1 	 number a
20 	 21 	 (NP\NP)/NP 	 1 	 number of
22 	 21 	 (NP\NP)/NP 	 2 	 areas of
<\s>
<s id="wsj_2099.4"> 20
1 	 0 	 (S/S)/(S[ng]\NP) 	 2 	 removing Beyond
3 	 1 	 (S[ng]\NP)/NP 	 2 	 competitor removing
3 	 2 	 NP[nb]/N 	 1 	 competitor a
6 	 5 	 NP[nb]/N 	 1 	 combination the
6 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 combination should
6 	 8 	 (S[b]\NP)/NP 	 1 	 combination provide <XB>
7 	 0 	 (S/S)/(S[ng]\NP) 	 1 	 should Beyond
7 	 11 	 (S[dcl]\S[dcl])/NP 	 1 	 should said
8 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 provide should
9 	 8 	 (S[b]\NP)/NP 	 2 	 synergies provide
13 	 11 	 (S[dcl]\S[dcl])/NP 	 2 	 Harlow said
13 	 12 	 N/N 	 1 	 Harlow Fred
15 	 16 	 (NP[nb]/N)\NP 	 2 	 Unilab 's
19 	 11 	 (S[dcl]\S[dcl])/NP 	 2 	 officer said
19 	 16 	 (NP[nb]/N)\NP 	 1 	 officer 's
19 	 17 	 N/N 	 1 	 officer chief
19 	 18 	 N/N 	 1 	 officer financial
<\s>
<s id="wsj_2099.5"> 7
0 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 It will
0 	 3 	 ((S[b]\NP)/NP)/NP 	 1 	 It hand <XB>
2 	 1 	 (S\NP)/(S\NP) 	 2 	 will also
3 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 hand will
4 	 3 	 ((S[b]\NP)/NP)/NP 	 3 	 Unilab hand
6 	 3 	 ((S[b]\NP)/NP)/NP 	 2 	 markets hand
6 	 5 	 N/N 	 1 	 markets new
<\s>
<s id="wsj_2099.6"> 27
2 	 0 	 (S/S)/NP 	 2 	 Angeles In
2 	 1 	 N/N 	 1 	 Angeles Los
5 	 4 	 (S/S)/NP 	 2 	 example for
7 	 8 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 Central has
7 	 9 	 (S[pt]\NP)/NP 	 1 	 Central had <XB>
8 	 0 	 (S/S)/NP 	 1 	 has In
8 	 4 	 (S/S)/NP 	 1 	 has for
9 	 8 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 had has
9 	 14 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 had while
9 	 23 	 ((S\NP)\(S\NP))/PP 	 2 	 had according
13 	 9 	 (S[pt]\NP)/NP 	 2 	 position had
13 	 10 	 NP[nb]/N 	 1 	 position a
13 	 11 	 N/N 	 1 	 position strong
13 	 12 	 N/N 	 1 	 position market
15 	 16 	 (NP[nb]/N)\NP 	 2 	 Unilab 's
17 	 16 	 (NP[nb]/N)\NP 	 1 	 presence 's
17 	 18 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 presence has
17 	 21 	 S[adj]\NP 	 1 	 presence prominent <XB>
18 	 14 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 has while
19 	 18 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been has
21 	 19 	 (S[pt]\NP)/(S[adj]\NP) 	 2 	 prominent been
21 	 20 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 prominent less
24 	 23 	 ((S\NP)\(S\NP))/PP 	 3 	 to according
26 	 24 	 PP/NP 	 1 	 Harlow to
26 	 25 	 N/N 	 1 	 Harlow Mr.
<\s>
